Delivery Order SPE2DB24D1205-SPE2DB24FCVBW

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract, valued at up to $2,467.08, is for the delivery of testosterone 1% (50 mg/5 g) pharmaceutical products. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
This federal contract award, valued at $2,282.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Testosterone 1% (25mg/2.5g) pharmaceutical products. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of September 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. The contract is likely...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Testosterone 1% (25mg/2.5g) pharmaceutical product, valued at $3,061.60. The contract is a Delivery Order issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of February 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,376.10, to provide the product "Testosterone 1% (25mg/2.5g) PK 2.5gm". The contract has a completion date of June 9, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,239.13 firm fixed-price delivery order is for the supply of Testosterone 1% (50 mg/5 g) pharmaceutical products. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., also known as Amerisourcebergen, valued at up to $999,999,999.00...
This federal contract award, valued at $1,340.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of testosterone 1% (50 mg/5 g) product, with a completion date of March 4, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,493.52, is for the delivery of Testosterone 1% (50 mg/5 g) in a 5 g package. The contract is a firm fixed-price delivery order with a completion date of March 10, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is a Delivery Order valued at $1,944.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TESTOSTERONE 1% (25MG/2.5G) PK 2.5GM, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.46 firm-fixed-price delivery order is for the supply of testosterone 1% (25mg/2.5g) pharmaceutical products. The contract has a completion date of November 1, 2024 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,266.96, is for the delivery of testosterone 1% (25mg/2.5g) pharmaceutical product. The contract has a completion date of February 19, 2025 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a for-profit organization and...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCVBW
    Delivery Order

This federal contract award, valued at $1,358.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of testosterone 1% (50 mg/5 g) pharmaceutical product, with a completion date of September 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, enabling them to efficiently supply a wide range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs, veterans' healthcare, and other government healthcare initiatives. This award is not associated with any set-aside designation.

Generated 12/26/24, 9:01 AM